MSTN and sarcopenia: Apart from well-established factors such as uremic toxins accumulation, protein loss during dialysis, metabolic acidosis, multiple comorbidities, myostatin and angiotensin II overexpression, hyperparathyroidism may also play a pivotal role in the pathogenesis of uremic sarcopenia (5).